Fig. 2From: Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort studyPrevalence of increased platelet reactivity (PRI VASP ≥61 %) in the transplant group vs. in the control group. PRI platelet reactivity index, VASP vasodilatator-stimulated phosphoproteinBack to article page